FTRE
Price
$5.43
Change
+$0.31 (+6.05%)
Updated
Jun 6, 04:21 PM (EDT)
Capitalization
463.45M
73 days until earnings call
JAZZ
Price
$111.18
Change
+$2.38 (+2.19%)
Updated
Jun 6, 04:59 PM (EDT)
Capitalization
6.71B
54 days until earnings call
Interact to see
Advertisement

FTRE vs JAZZ

Header iconFTRE vs JAZZ Comparison
Open Charts FTRE vs JAZZBanner chart's image
Fortrea Holdings
Price$5.43
Change+$0.31 (+6.05%)
Volume$872
Capitalization463.45M
Jazz Pharmaceuticals
Price$111.18
Change+$2.38 (+2.19%)
Volume$11.88K
Capitalization6.71B
FTRE vs JAZZ Comparison Chart
Loading...
FTRE
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
JAZZ
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
FTRE vs. JAZZ commentary
Jun 06, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is FTRE is a Buy and JAZZ is a StrongBuy.

Interact to see
Advertisement
COMPARISON
Comparison
Jun 06, 2025
Stock price -- (FTRE: $5.12 vs. JAZZ: $108.82)
Brand notoriety: FTRE and JAZZ are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: FTRE: 101% vs. JAZZ: 51%
Market capitalization -- FTRE: $463.45M vs. JAZZ: $6.71B
FTRE [@Biotechnology] is valued at $463.45M. JAZZ’s [@Biotechnology] market capitalization is $6.71B. The market cap for tickers in the [@Biotechnology] industry ranges from $323.27B to $0. The average market capitalization across the [@Biotechnology] industry is $2.32B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

FTRE’s FA Score shows that 1 FA rating(s) are green whileJAZZ’s FA Score has 0 green FA rating(s).

  • FTRE’s FA Score: 1 green, 4 red.
  • JAZZ’s FA Score: 0 green, 5 red.
According to our system of comparison, FTRE is a better buy in the long-term than JAZZ.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

FTRE’s TA Score shows that 4 TA indicator(s) are bullish while JAZZ’s TA Score has 4 bullish TA indicator(s).

  • FTRE’s TA Score: 4 bullish, 3 bearish.
  • JAZZ’s TA Score: 4 bullish, 3 bearish.
According to our system of comparison, JAZZ is a better buy in the short-term than FTRE.

Price Growth

FTRE (@Biotechnology) experienced а +22.51% price change this week, while JAZZ (@Biotechnology) price change was +0.52% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +11.61%. For the same industry, the average monthly price growth was +17.33%, and the average quarterly price growth was +3.50%.

Reported Earning Dates

FTRE is expected to report earnings on Aug 18, 2025.

JAZZ is expected to report earnings on Jul 30, 2025.

Industries' Descriptions

@Biotechnology (+11.61% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
JAZZ($6.71B) has a higher market cap than FTRE($463M). JAZZ YTD gains are higher at: -11.636 vs. FTRE (-72.542). JAZZ has higher annual earnings (EBITDA): 1.25B vs. FTRE (-64.3M). JAZZ has more cash in the bank: 2.57B vs. FTRE (118M). FTRE has less debt than JAZZ: FTRE (1.2B) vs JAZZ (5.42B). JAZZ has higher revenues than FTRE: JAZZ (4.07B) vs FTRE (2.7B).
FTREJAZZFTRE / JAZZ
Capitalization463M6.71B7%
EBITDA-64.3M1.25B-5%
Gain YTD-72.542-11.636623%
P/E RatioN/A14.79-
Revenue2.7B4.07B66%
Total Cash118M2.57B5%
Total Debt1.2B5.42B22%
FUNDAMENTALS RATINGS
JAZZ: Fundamental Ratings
JAZZ
OUTLOOK RATING
1..100
4
VALUATION
overvalued / fair valued / undervalued
1..100
69
Overvalued
PROFIT vs RISK RATING
1..100
100
SMR RATING
1..100
60
PRICE GROWTH RATING
1..100
63
P/E GROWTH RATING
1..100
87
SEASONALITY SCORE
1..100
n/a

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
FTREJAZZ
RSI
ODDS (%)
Bullish Trend 2 days ago
75%
Bullish Trend 2 days ago
74%
Stochastic
ODDS (%)
Bearish Trend 2 days ago
90%
Bearish Trend 2 days ago
61%
Momentum
ODDS (%)
Bullish Trend 2 days ago
71%
Bullish Trend 2 days ago
62%
MACD
ODDS (%)
Bullish Trend 2 days ago
65%
Bullish Trend 2 days ago
77%
TrendWeek
ODDS (%)
Bullish Trend 2 days ago
69%
Bullish Trend 2 days ago
63%
TrendMonth
ODDS (%)
Bearish Trend 2 days ago
81%
Bearish Trend 2 days ago
61%
Advances
ODDS (%)
Bullish Trend 3 days ago
69%
Bullish Trend 4 days ago
61%
Declines
ODDS (%)
Bearish Trend 22 days ago
84%
Bearish Trend 2 days ago
56%
BollingerBands
ODDS (%)
Bearish Trend 2 days ago
73%
N/A
Aroon
ODDS (%)
N/A
N/A
View a ticker or compare two or three
Interact to see
Advertisement
FTRE
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
JAZZ
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
ACFDX67.13N/A
N/A
American Century Focused Dynamic Gr A
GSTTX13.63N/A
N/A
Goldman Sachs Strategic Growth Inv
UINQX53.57N/A
N/A
Victory Nasdaq 100 Index Institutional
PLAEX30.10N/A
N/A
Plumb Equity A
NWAOX34.30N/A
N/A
Nationwide BNY Mellon Dyn US Eq Inc I.S

FTRE and

Correlation & Price change

A.I.dvisor indicates that over the last year, FTRE has been loosely correlated with BHVN. These tickers have moved in lockstep 40% of the time. This A.I.-generated data suggests there is some statistical probability that if FTRE jumps, then BHVN could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To FTRE
1D Price
Change %
FTRE100%
+10.60%
BHVN - FTRE
40%
Loosely correlated
-0.06%
TECH - FTRE
39%
Loosely correlated
-3.15%
DNLI - FTRE
39%
Loosely correlated
-1.35%
XERS - FTRE
38%
Loosely correlated
+0.68%
SYRE - FTRE
38%
Loosely correlated
+0.54%
More